Studying 113 recalls from 2005-2009 that could cause serious health problems or death, researchers found 71 percent were cleared through the less rigorous process and an additional 7 percent were exempted from any FDA regulation.
Researchers also found that 31 percent of the high-risk device recalls were in cardiology and 51 percent were in one of five other categories: general hospital, anesthesiology, clinical chemistry, neurology and ophthalmology.
Related Articles in Medical Device Recalls:
American Regent Initiates Recall of Vasopressin Injection Lots
Infusion Pumps Plagued by Multiple FDA Recalls
GAO Report: FDA Should Tighten Oversight of Device Recalls
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
